Purple Biotech Reports First Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: May 21, 2025
Final CM24 Phase 2 data presented at AACR Annual Meeting 2025, strengthening patient selection strategy for CM24 Phase 2b study planned to be initiated in Second Half of 2025
Read more at globenewswire.comNASDAQ:PPBT (9/11/2025, 2:32:30 PM)
0.5752
+0.01 (+2.49%)
Find more stocks in the Stock Screener
PPBT Latest News and Analysis
